The World Health Organization has approved a version of a widely used cholera vaccine that could help address a surge in cases that has depleted the global vaccine stockpile and left poorer countries scrambling to contain epidemics.
WHO authorized the vaccine, made by EuBiologics, which also makes the formulation now used, last week. The new version, called Euvichol-S, is a simplified formula that uses fewer ingredients, is cheaper, and can be made more quickly than the old version.
The vaccine was shown to be help preventing the diarrheal disease in late stage research conducted in Nepal.
WHO’s approval means donor agencies like the vaccines alliance Gavi and UNICEF can now buy it for poorer countries. Leila Pakkala, director of UNICEF’s supply division, said in a statement that the agency will be able to boost supplies by more than 25%.
Former Wisconsin Democratic Rep. Peter Barca announces new bid for Congress
Xi Sends Congratulatory Letter to 2023 Beijing Culture Forum
HK's tourism continues rebound in 2023 with 34m visitors
Development of nation's central region in focus
Rybakina, Vondroušová into Stuttgart quarters while Jabeur out
Xi Sends Congratulatory Letter to 2023 Pujiang Innovation Forum
Exports of Taiwan liquor from mainland thrive
Chinese police take back 130 gambling, scam suspects from Cambodia
The Patriots enter the NFL draft needing a QB, but could trade down to fill other needs
Xi, Maduro Announce Elevation of China
Tom Schwartz rates Las Vegas kiss with Scheana Shay a FIVE as he brands it 'weird': 'So platonic'
Pucksters back in the big time